03:08 AM EDT, 08/25/2025 (MT Newswires) -- Eric Venker, President & Immunovant Chief Executive Officer, on August 20, 2025, sold 100,000 shares in Roivant Sciences ( ROIV ) for $1,172,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,653,585 common shares of the company, with 1,653,585 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000114036125032404/xslF345X05/form4.xml